The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing ...

Endocrine-disease-focused Visen Pharmaceuticals is making its public market debut in Hong Kong, filing papers for an $86.5 ...

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on Wednesday, April 2nd, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.50-$8.50 per share. The ...

DNA sequencing specialist’s decision to list in London in 2021 was seen as a victory for the market at the time ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Discover how PomDoctor Limited aims to revolutionize China's telehealth industry with a $15M IPO, despite facing stiff ...

Icelandic biotechnology company Alvotech intends to explore the possibility of a Stockholm listing as it announced the acquisition of a Swedish research and development operation and drug candidate.

The pharma is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer and ...

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...